Biopharma Competition Patients Prospecting 
PM360
FEBRUARY 1, 2024
Embarking on the journey from product development to market success in the biopharma industry is no small feat. The landscape is highly competitive with new prescription medications launching worldwide each year. However, this journey is fraught with challenges as revealed by an in-depth analysis.
PM360
DECEMBER 20, 2023
With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This allows for a complementary portfolio fit without the kind of competitive overlap that comes under regulatory scrutiny from the FTC.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
APRIL 7, 2023
Biopharma should pay special attention to this. The human interaction deficit is on average more pronounced in patients living with serious health conditions. As we plan our patient engagement strategies for the coming years, in-person interactions must be central to our vision. Trust Patient engagement is about building trust.
PM360
NOVEMBER 12, 2023
While the global biopharma industry retains its huge dependence on the U.S. This should, at least in theory, make them an appealing target for biopharma companies looking to expand beyond the hugely competitive markets of the U.S., market, emerging markets present great opportunities for biotech and pharmaceutical companies.
PM360
APRIL 22, 2024
In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. ABIGAIL MALLON Chief Patient Experience Officer, VMS BioMarketing Physician burnout is on the rise. The second to increase in patient-oriented communication and support for physicians.
Zymewire
FEBRUARY 8, 2024
Skip to a topic Axonis' journey and purpose The impact of the economic client on emerging biopharma The place of Artificial Intelligence in drug development & discovery Working with NASA Relationships with CROs, CDMOs, and other service providers What made you want to start Axonis? What unmet needs are you hoping to address for patients?
Clarivate
DECEMBER 6, 2022
In a fiercely competitive U.S. These health systems combine multiple sites and services, and sometimes a health maintenance organization, to provide end-to-end care to patients locally or regionally. states and the United Kingdom and sees more than 35 million patient encounters per year. ChristianaCare, Wilmington, Delaware.
Expert insights. Personalized for you.
59 
Let's personalize your content